Stay updated on IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial

Sign up to get notified when there's something new on the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 across the site. No changes to study content or functionality are indicated.
    Difference
    0.1%
    Check dated 2026-03-25T19:55:44.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T15:38:49.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    The page was updated to Revision v3.4.2 and the government funding lapse notice was removed; no core trial information, eligibility criteria, or patient-facing content were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:28:12.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Status updated to Active, not recruiting, and results have been posted with key outcomes (ARR, ORR, DCR, PFS). The page now includes linked study documents (Protocol and Statistical Analysis Plan) and updated dates, enrollment, and locations.
    Difference
    4%
    Check dated 2026-02-04T05:58:35.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated capitalization for QC-related labels and revision text; these changes are cosmetic and do not affect study content or user tasks.
    Difference
    0.2%
    Check dated 2026-01-28T04:14:57.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; this update appears to be metadata only with no substantive changes to the study content or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:22:29.000Z thumbnail image

Stay in the know with updates to IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page.